Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

MoPH Calls on the Energy and Water Ministry to Identify Polluted Sea Areas and Take Measures according to Law No. 77/2018

 
The Information Office of the Ministry of Public Health issued the following statement:

There have been lately conflicting reports issued by official and unofficial sources concerning the polluted beaches in Lebanon, knowing that Law No. 77/2018, in particular articles 26, 17, 28 and 32 of the same stipulate that controlling the quality of surface water, groundwater and coastal water falls under the responsibility of the Energy and Water Ministry. It is therefore important to officially identify the polluted beaches and inform the citizens, given the health damages pollution can cause to beachgoers.

Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani wrote to the Energy and Water Ministry asking this latter to notify the Ministry of Public Health of the periodic tests’ results to assess the validity of the two conflicting reports issued by LARI’s Director General Dr. Michel Ephrem and the CNRS’ secretary General in order to prevent the citizens from swimming in polluted beaches.

In this context, it is worth noting that some research may not have been conducted based on scientific standards. The competent authority should identify the quality of water and take the necessary measures.
    ...
    194
ATC Name B/G Ingredients Dosage Form Price
L01FA01 ZYTUX BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 27,724,196 L.L
J01XX08 ZYVOX B Linezolide - 600mg 600mg Tablet 35,584,461 L.L
J01XX08 ZYVOX IV B Linezolide - 600mg/300ml 600mg/300ml Injectable solution 4,414,523 L.L
N01BB02 α 1% LIDOCAINE HCL USP G Lidocaine HCl - 1% 1% Injectable solution 76,791 L.L
N01BB02 α 2% LIDOCAINE HCL USP G Lidocaine HCl - 2% 2% Injectable solution 255,970 L.L
H02AB02 α DEXAMETHASONE SODIUM PHOSPHATE USP G Dexamethasone (sodium phosphate) - 8mg/2ml 8mg/2ml Injectable solution 44,795 L.L
C03CA01 α FUROSEMIDE INJECTION G Furosemide - 20mg/ml 20mg/ml Injectable solution 25,597 L.L
A03BB01 α HYOSCINE BUTYLBROMIDE G Hyoscine butylbromide - 20mg/ml 20mg/ml Injectable solution 70,392 L.L
M01AE01 α IBUPROFEN G Ibuprofen - 400mg/100ml 400mg/100ml Injectable solution 383,955 L.L
A03FA01 α METOCLOPRAMIDE INJECTION USP G Metoclopramide HCl - 10mg/2ml 10mg/2ml Injectable solution 84,470 L.L
P01AB01 α METRONIDAZOL G Metronidazole - 500mg/100ml 500mg/100ml Injectable solution 162,541 L.L
C01CA03 α NORADRENALINE G Norepinephrine tartrate - 8mg/4ml 8mg/4ml Injectable solution 330,201 L.L
A04AA01 α ONDANSETRON USP G Ondansetron - 8mg/4ml 8mg/4ml Injectable solution 447,948 L.L
N02BE01 α PARACETAMOL G Paracetamol - 1g/100ml 1g/100ml Injectable solution 191,978 L.L
N03AB02 α PHENYTOIN SODIUM 5% USP G Phenytoin (sodium) - 250mg/5ml 5ml Injectable solution 276,448 L.L
V03AB35 α SUGAMMADEX G Sugammadex - 200mg/2ml 100mg/ml Injectable solution 5,214,109 L.L
    ...
    194
Sitemap
© Copyrights reserved to Ministry of Public Health 2026